Skip to main content
Quest Diagnostics

Lexicon for Blood-Based Early Detection and Screening: BLOODPAC Consensus Document

Lexicon for Blood-Based Early Detection and Screening: BLOODPAC Consensus Document

Authors: Clarke CA, Mitchell BL, Putcha G, Alme E, Bach P, Beer JP, Beer TM, Beidelschies MA, Hoyos J, Klein E, Kuhn P, Krunic N, Lang K, Lee JSH, Lopez Ramos D, Morgenstern D, Quinn E, Raymond VM, Rubinstein WS, Sanchez SA, Serra R, Stewart M, Leiman LC

Citation: Clin Transl Sci. 2024 Aug 28. doi: 10.1111/cts.70016. Online ahead of print

Specialties: Oncology

Related content

Publication
BLOODPAC: Collaborating to chart a path towards blood-based screening for early cancer detection
On-Demand Webinar
Early Detection Better Protection - Colorectal Cancer Screening in the Workplace: A Panel Discussion
Publication
Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans
Test FAQ
Haystack MRD Testing
Audio Podcast
Molecular Expression Through the Eyes of the Pathologist and Oncologist

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.